by ASTCT Talks
In the next installment of ASTCT's Titans of Transplant series, Dr. Shernan Holtan sits down with Dr. Daniel Weisdorf—renowned leader, mentor and pioneer in cellular therapy and...
by David Porter, MD
In this month's President’s Message, Dr. David Porter shares his perspective on the recent dismissal of the CDC’s vaccine advisory committee—and why it matters.
by ASTCT Talks
An expert panel highlights key presentations in multiplemyeloma, lymphoma, and other hematologic malignancies at the 2025 ASCO Annual Meeting.
CancerNetwork®, in collaboration with The...
by ASTCT Talks
In this episode of ASTCT Talks, Dr. Taha Al-Juhaishi welcomes Dr. Marcos de Lima, hematologist-oncologist at The Ohio State University Comprehensive Cancer Center, to explore the rapidly evolving...
by ASTCT Advocacy Update
ASTCT Submits Recommendations to OMB to Improve Access to Stem Cell and Cellular Therapies
by David Porter, MD
In this month's president's message, Dr. David Porter shares why staying engaged with ASTCT’s email communications is more important than ever.